EPA AND DHA MARKET ANALYSIS

EPA and DHA MarketSize and Trends

The global EPA and DHA market size was valued at USD 1,626.10 million in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 6.76% from 2022 to 2030. Growing demand for concentrated form of omega-3 ingredients is predominantly fueling growth of the EPA and DHA market. Moreover, increasing demand for high purity krill oils, high-concentrate fish oils, and purified algal oils are again expected to foster market growth. Furthermore, rise in number of research activities to develop products with improved absorption/utilization of omega-3 concentrates in dietary supplements and pharmaceuticals are further anticipated to augment market growth.

Global EPA and DHA Market: Regional Insights

Figure 1. Global EPA and DHA Market Value Share (%), By Region, 2021

Global EPA and DHA Market Drivers:

Growing demand for high purity krill oils, high-concentrate fish oils, and purified algal oils are primarily fueling growth of the EPA and DHA market. Moreover, increasing number of research and development activities for introducing new products that has better absorption properties is again anticipated to foster market growth.

Increasing demand for dietary supplements due to growing health awareness is again anticipated to foster market growth. Moreover, increasing demand for EPA in drug application is propelling growth of the market. The segment is witnessing strong growth due to its potential health benefits especially for adult.

Global EPA and DHA Market Trends:

Growing demand for vegan products and additives is gaining traction in the market. In recent years, the demand for vegan ingredients and products has been gaining popularity among consumers around the globe, driving various companies to invest heavily in product innovations and research and development to cater to this growing demand. Moreover, shifting consumer preferences of consumer from animal protein to plant protein is augmenting growth of the market.

New product launch in algae-based Omega-3 is expected to be major trend in the market. For instance, in June 2019, ADM unveiled a new line of DHA/EPA blends containing omega 3, 6, and 9, which offer benefits that can help support cognitive, heart, immune system, or eye health. Coined “Onavita Algal DHA” and “Almega EPA,” the new blends were created in collaboration with Qualitas Health, a marketer in algae cultivation.